Please login to the form below
Evotec
This page shows the latest Evotec news and features for those working in and with pharma, biotech and healthcare.
Almirall and Evotec team up in multi-target dermatology alliance
Evotec will oversee drug discovery and pre-clinical development, while Almirall will lead the clinical development and marketing. ... We are looking forward to leveraging the complementary expertise of Evotec and Almirall in order to develop promising
Latest news
-
Bayer bulks up in women’s health again with non-hormonal contraceptive deal
It remains firmly committed to women’s health however, and just last week added to its pipeline in this area by signing a five-year research alliance with Evotec focusing on ... The Evotec and Daré deals sandwiched two other agreements signed in the
-
Bayer extends alliance with Evotec in women’s health
There has been little progress in how these and other related conditions are diagnosed and treated, according to Evotec. ... Bayer and Evotec will both contribute drug targets to the alliance as well as other technology platforms, and will jointly
-
Evotec and Vifor announce joint venture for kidney disease treatments
Evotec’s proprietary PanHunter bioinformatics drug discovery platform has already attracted a number of deals with big pharma and Celgene, among others. ... in nephrology clinical development and commercialisation,” said Cord Dohrmann, chief
-
Evotec spins off cancer tech into new Breakpoint company
Will challenge AstraZeneca and others in DNA damage response. German biotech Evotec has decided to bundle its cancer therapeutic programmes focused on DNA damage response (DDR) into a new spin-off ... virtual” spin out that will still have access to
-
Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity
This deal extends Exscientia’s list of partnerships with pharma and biotech companies, with existing collaborations involving Roche, GSK, Sanofi and Evotec.
More from news
Approximately 17 fully matching, plus 24 partially matching documents found.
Latest Intelligence
-
Alzheimer’s disease: the search for a cure
The companies, Abbvie, Astex Pharmaceuticals, Eisai, Johnson &Johnson, Lilly, MSD and Takeda, Evotec and Charles River, participate in research projects alongside academic scientists.
-
A snapshot of… Exscientia
We’ve also signed numerous major pharma collaborations with companies including Roche, Celgene, Sanofi, GSK and Evotec, estimated to be worth over $1bn in milestones and royalties.
-
Brain power: fresh approaches to Alzheimer’s drug discovery
Last month, Johnson &Johnson Innovation, Takeda and Evotec became the latest pharma research groups to join the initiative, alongside existing strategic partners AbbVie, Astex Pharmaceuticals, Eisai, Lilly and MSD. ... We’re excited to welcome Johnson
-
Pharma deals continue to slide
For example, Evotec, the German small molecule development company, is acquiring for $300m the US preclinical development company, Aptuit. ... 400. Aptuit (US). Evotec (DE). Company acquisition. Drug discovery and development to IND submission including
-
Deal Watch December 2016
320. Evotec (Germany). Celgene (US). Discovery collaboration. Induced pluripotent stem cells for neurodegenerative diseases. ... upfront. And although the upfronts are a modest percentage of the headline figure, ranging from < 1% (BioInvent) to 15%
More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.
Latest appointments
-
Apitope strengthens its board with new director
He has also served on several boards including Ablynx, Evotec and Acambis.
-
Evotec CEO Werner Lanthaler temporarily stands down
Cites health reasons. Evotec's CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Breaking the silence: It’s time to talk about the menopause
According to Werner Lanthaler, CEO of Evotec AG (a long-time partner of Bayer AG, well-known for their role in advocating for women’s health) in an interview with In
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- A new era for UK-Japanese scientific research relations
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Realising the potential of omnichannel in medical communications
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Six UK universities receive grant for research into motor neurone disease
- My journey advancing the science in pulmonary hypertension
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
